COMMUNIQUÉS West-GlobeNewswire

-
Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors - Corrected Version
21/05/2019 -
Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties
21/05/2019 -
MediPharm Labs Announces Addition to $1.2B MJ ETFMG Alternative Harvest ETF (USA)
21/05/2019 -
Emerald Health Therapeutics tiendra une conférence téléphonique sur ses résultats financiers du premier trimestre 2019 le 31 mai prochain
21/05/2019 -
Metacrine to Present at Jefferies 2019 Global Healthcare Conference
21/05/2019 -
Acasti Pharma to Present at the 20th Annual B. Riley FBR Institutional Investor Conference
21/05/2019 -
Crinetics Pharmaceuticals Initiates Phase 1 Study of CRN01941 for the Treatment of Neuroendocrine Tumors
21/05/2019 -
Emerald Health Therapeutics to Hold Conference Call on First Quarter 2019 Financial Results on May 31st
21/05/2019 -
BioCryst’s Oral BCX7353 Meets Primary Endpoint in Phase 3 APeX-2 Trial
21/05/2019 -
Axsome Therapeutics To Present Data From ASCEND Phase 2 Trial Of AXS-05 In Major Depressive Disorder At The 2019 American Society For Clinical Psychopharmacology Annual Meeting
21/05/2019 -
Invivoscribe Expanding Clinical Laboratory Network Space and Testing Capabilities in San Diego, Germany, Japan, and China. Offering Comprehensive Standardized Testing for All Hematologic Malignancies
21/05/2019 -
Transactions in relation to share buyback program
21/05/2019 -
Santhera Starts Collaboration in Gene Therapy Research for Congenital Muscular Dystrophy with the Biozentrum, University of Basel, Co-Financed by Innosuisse
21/05/2019 -
Motif Bio to Present Iclaprim Data at ASM Microbe 2019
21/05/2019 -
Preclinical study of GKT831 shows rapid regression of cholestatic fibrosis in model of advanced liver fibrosis
21/05/2019 -
Une étude préclinique du GKT831 montre une régression rapide de la fibrose cholestatique dans un modèle de fibrose hépatique avancée
21/05/2019 -
Anne ABRIAT-HEMMENDINGER appointed to the Board of Directors of DEINOVE
21/05/2019 -
Curetis to Receive Additional EUR 6.5 Million Financing from EIB and Yorkville
21/05/2019 -
Novelion Therapeutics Announces Subsidiary Aegerion Pharmaceuticals to Recapitalize Through Court Supervised Process In Which Amryt Pharma Plc Will Acquire 100% of Reorganized Stock of Aegerion
21/05/2019
Pages